Trial intelligence / Profile preview

Leuprolide vs Oral Contraceptives for Ovarian Hyperandrogenism

NCT00004763Phase 2Completed

Sponsor
National Center for Research Resources
Start
Jan 1993
Modality
Peptides, Small Molecules
01

Overview

A Phase 2 trial of leuprolide in Ovarian hyperandrogenism, sponsored by National Center for Research Resources. Started Jan 1993; status: completed.

02

Drugs

leuprolide
03

Conditions

Ovarian hyperandrogenism

Beyond the preview

Go deeper on NCT00004763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call